| __timestamp | HUTCHMED (China) Limited | Merck & Co., Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 91813000 | 42237000000 |
| Thursday, January 1, 2015 | 178203000 | 39498000000 |
| Friday, January 1, 2016 | 216080000 | 39807000000 |
| Sunday, January 1, 2017 | 241203000 | 40122000000 |
| Monday, January 1, 2018 | 214109000 | 42294000000 |
| Tuesday, January 1, 2019 | 204890000 | 46840000000 |
| Wednesday, January 1, 2020 | 227976000 | 41518000000 |
| Friday, January 1, 2021 | 356128000 | 48704000000 |
| Saturday, January 1, 2022 | 426409000 | 59283000000 |
| Sunday, January 1, 2023 | 837999000 | 60115000000 |
Data in motion
In the ever-evolving pharmaceutical landscape, Merck & Co., Inc. and HUTCHMED (China) Limited present a fascinating study in contrasts. Over the past decade, Merck has consistently demonstrated its market dominance, with revenues soaring from $42 billion in 2014 to an impressive $60 billion by 2023. This represents a robust growth of approximately 43% over the period.
Meanwhile, HUTCHMED, a rising star in the industry, has shown remarkable growth, albeit on a smaller scale. Starting with revenues of just $92 million in 2014, the company has achieved a staggering 811% increase, reaching $838 million in 2023. This growth trajectory underscores HUTCHMED's potential to disrupt the market.
As these two companies continue to navigate the complexities of the global market, their contrasting revenue trends offer valuable insights into the dynamics of the pharmaceutical industry.
Johnson & Johnson and Merck & Co., Inc.: A Comprehensive Revenue Analysis
Breaking Down Revenue Trends: Merck & Co., Inc. vs Teva Pharmaceutical Industries Limited
Comparing Revenue Performance: Merck & Co., Inc. or Halozyme Therapeutics, Inc.?
Merck & Co., Inc. vs Dynavax Technologies Corporation: Examining Key Revenue Metrics
Gilead Sciences, Inc. or HUTCHMED (China) Limited: Who Leads in Yearly Revenue?
Dr. Reddy's Laboratories Limited and HUTCHMED (China) Limited: A Comprehensive Revenue Analysis
Revenue Insights: Bio-Techne Corporation and HUTCHMED (China) Limited Performance Compared
Revenue Showdown: Amneal Pharmaceuticals, Inc. vs HUTCHMED (China) Limited
Who Generates More Revenue? PTC Therapeutics, Inc. or HUTCHMED (China) Limited
Revenue Insights: HUTCHMED (China) Limited and ImmunityBio, Inc. Performance Compared
HUTCHMED (China) Limited and Geron Corporation: A Comprehensive Revenue Analysis
Revenue Insights: HUTCHMED (China) Limited and BioCryst Pharmaceuticals, Inc. Performance Compared